Biostasis Technologies Inc (EIN 881631797) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

Aschwin de Wolf

Phone

9547668433

Tax Period

2025-01-01 to 2025-12-31

Biostasis Technologies Inc, founded in 2022, is a small nonprofit in the Medical Research sector that reported $937K in total revenue in fiscal year 2025. Expenses of $835K left a modest 11% surplus.

Mission

To conduct and support scientific research and education focusing primarily on hypothermic tissue stabilization for organ preservation brain banking anatomical donation and human biostasis.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $934,920

Program Service Revenue $2,100

Investment Income $0

Other Revenue $0

TOTAL REVENUE $937,020

Expense Breakdown

Grants Paid $0

Salaries & Benefits $531,926

Fundraising Expenses $0

Program Expenses $565,956

Other Expenses $303,266

TOTAL EXPENSES $835,192

Year-over-Year Comparison

	2025	2024	Change
Revenue	$937,020	$868,209	+0.1%
Expenses	$835,192	$848,980	0.0%
Net Income	$101,828	$19,229	+4.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$120,677

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michael Benjamin	Secretary Treasurer	40.00	Officer	$120,677	$0	$120,677
Houston Westfall	Director	4.00	Director	$0	$0	$0
Carrie Radomski	Director	4.00	Director	$0	$0	$0
Benjamin Best	Director	4.00	Director	$0	$0	$0
Aschwin de Wolf	President	40.00	Officer	$0	$0	$0
Keegan Macintosh	Director	4.00	Director	$0	$0	$0
Max More	Director of Communications	40.00	Highest	$106,436	$4,257	$110,693
Lauren Fosco	Chief Operating Officer	40.00	Highest	$132,429	$3,857	$136,286

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$937,020	$835,192	$155,286	$101,828
2024	$868,209	$848,980	$396,423	$19,229
2023	$559,929	$537,100	$170,767	$22,829
2022	$169,164	$158,164	$216,774	$11,000

Biostasis Technologies Inc